Evidence map›Paper›PMID 42856740›Full record

ArticleFrontiers in nutrition2026

Discovery of sunflower-derived umami peptides via machine learning and molecular dynamics simulation of their interactions with the T1R1/T1R3 receptor.

Zimo Zhang, Fei Ye, Haifeng Zhao, Xiaozheng Shi

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zimo ZhangSchool of Life Sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang, China.
Fei Ye *School of Biological and Pharmaceutical Engineering, Jilin Agricultural Science and Technology College, Jilin City, China.
Haifeng Zhao *Jilin Institute for Drug Control, Changchun, China.
Xiaozheng Shi *Changchun University of Chinese Medicine, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Umami recognition relies on T1R1/T1R3 binding with umami peptides, but the interaction mechanisms remain unclear. This study aims to reveal the taste mechanisms of four potential umami peptides at both sensory and molecular levels. Methods: Electronic tongue evaluations were performed to assess umami and richness intensities. Principal component analysis (PCA) was used to discriminate the peptides. Molecular docking and 200 ns molecular dynamics (MD) simulations were conducted to characterize the binding modes and conformational dynamics of peptide-receptor complexes. Results: Electronic tongue evaluation showed that ELLADMK exhibited the highest umami (1.05) and richness (1.77) intensities, followed by LEELMDK (umami: 0.97), HELDTK (umami: 0.72), and ADVLEK (umami: 0.49). PCA effectively discriminated these peptides, accounting for 93.8% of the total variance (PC1: 71.8%, PC2: 22.0%). Molecular docking and 200 ns MD simulations revealed that umami peptide binding decreased the conformational stability of the Venus flytrap domain, induced conformational expansion (e.g., in the ELLADMK system, RMSD increased from 2-4 Å to 8-10 Å, and Rg increased from 31.0-31.5 Å to 32.0-32.5 Å), and altered solvent accessibility in key regions. Notably, ELLADMK exhibited the most prominent modulatory effect. Discussion: These findings clarify the sensory and molecular mechanisms underlying umami peptide recognition. The pronounced modulatory effect of ELLADMK suggests its potential as a highly active umami peptide. Overall, this study provides a theoretical basis for the targeted screening of highly active umami peptides and for precise flavor regulation.

Indexed as

machine learningmolecular dynamics simulationsunflowerT1R1/T1R3 receptorumami peptides

Identifiers

PMID42856740
PMCPMC13650002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.